Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Total Debt (2016 - 2017)

Lisata Therapeutics' Total Debt history spans 8 years, with the latest figure at $450315.0 for Q2 2017.

  • For Q2 2017, Total Debt fell 94.89% year-over-year to $450315.0; the TTM value through Jun 2017 reached $450315.0, down 94.89%, while the annual FY2016 figure was $5.7 million, 62.32% down from the prior year.
  • Total Debt reached $450315.0 in Q2 2017 per LSTA's latest filing, down from $7.6 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $15.0 million in Q3 2014 to a low of $213112.0 in Q4 2013.
  • Average Total Debt over 5 years is $6.3 million, with a median of $3.6 million recorded in 2013.
  • Peak YoY movement for Total Debt: surged 808.21% in 2014, then crashed 94.89% in 2017.
  • A 5-year view of Total Debt shows it stood at $213112.0 in 2013, then soared by 808.21% to $1.9 million in 2014, then surged by 674.99% to $15.0 million in 2015, then tumbled by 62.32% to $5.7 million in 2016, then tumbled by 92.03% to $450315.0 in 2017.
  • Per Business Quant, the three most recent readings for LSTA's Total Debt are $450315.0 (Q2 2017), $7.6 million (Q1 2017), and $5.7 million (Q4 2016).